A Randomized, Single-Blind, Active-Controlled, Dose-Ranging Study To Evaluate PK, Safety, and Efficacy of Local Administration of DepoTXA for Reduced Post-Surgical Bleeding in Subjects Undergoing TKA

Next Previous
Trial Profile

A Randomized, Single-Blind, Active-Controlled, Dose-Ranging Study To Evaluate PK, Safety, and Efficacy of Local Administration of DepoTXA for Reduced Post-Surgical Bleeding in Subjects Undergoing TKA

Discontinued
Phase of Trial: Phase II

Latest Information Update: 18 Dec 2017

At a glance

  • Drugs Tranexamic acid (Primary)
  • Indications Haemorrhage
  • Focus Therapeutic Use
  • Sponsors Pacira Pharmaceuticals

    • Most Recent Events

    • 11 Dec 2017 Status changed from recruiting to discontinued.
    • 12 Oct 2017 Planned End Date changed from 1 Jul 2017 to 1 Jun 2018.
    • 12 Oct 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Mar 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top